Purchase Order HT941026PE020
- Not listed
- The Defense Health Agency awarded a $244.4K firm-fixed-price purchase order to National Jewish Health for beryllium lymphocyte proliferation testing services. The contract, effective January 31, 2023, extends through January 31, 2026, with performance taking place at Joint Base Pearl Harbor Hickam, Hawaii. No set-aside designation was utilized for this award. National Jewish Health, a Denver-based nonprofit hospital and research institution, specializes in respiratory and immunological...
- This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) to the non-profit hospital and research center National Jewish Health. The contract is a Definitive Contract with a Cost No Fee pricing type, and has a potential value of $67,944.99. National Jewish Health provides a range of specialized services to federal agencies, including diagnostic testing, animal research services, clinical trial support, and medical research. This contract...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to National Jewish Health, a non-profit hospital and research center, to provide research laboratory animal services. The contract has a firm-fixed price of $538,205.54 and a completion date of August 31, 2021. It was awarded on September 28, 2017 and does not have a set-aside designation. National Jewish Health has provided a range of goods and services to federal agencies...
- This is a cost-no-fee delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to National Jewish Health, a non-profit hospital and research center in Denver, Colorado. The contract, titled "LUNG TISSUE RESEARCH CONSORTIUM: TISSUE REPOSITORY," has a ceiling value of $338,145.22 and a period of performance from January 1, 2016, to December 31, 2020. The contract is not set-aside and is part of the...
- This $79,000 firm fixed-price purchase order was awarded on July 3, 2019 by the Centers for Disease Control and Prevention (CDC) to National Jewish Health, a non-profit hospital and research center in Denver, Colorado. The contract is for HRCT scans and a computer algorithm, with a period of performance through February 12, 2025. National Jewish Health is an experienced federal contractor, holding several indefinite delivery vehicles (IDVs) with the National Heart, Lung, and Blood Institute...
- The Defense Health Agency awarded a $828,024.90 firm fixed price delivery order to Biofire Defense LLC under an unspecified contract vehicle. The order is for respiratory panel testing services to support DHA programs. Work will be performed in Salt Lake City, Utah through December 31, 2021. The prime contractor will provide respiratory disease diagnostic panels to assist the Defense Health Agency in monitoring the health of military personnel. No subcontractors or set-aside designations were...
- The Defense Health Agency awarded Laboratory Corporation of America (Labcorp) a $876,000 firm fixed-price delivery order for clinical reference laboratory testing services at Nellis Air Force Base, Nevada, with performance extending through September 30, 2026. This delivery order, issued without set-aside designation, represents a child contract under a larger Defense Health Agency vehicle that provides streamlined procurement of diagnostic testing services across military medical facilities....
- The Defense Health Agency awarded a $14,983.68 Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on January 17, 2026, for test and measurement supplies for medical laboratory use. The contract, which carries a firm fixed price structure with no set-aside designation, will be performed in Portage, Michigan, and is scheduled for completion by September 30, 2026. Phadia US Inc., a foreign-owned subsidiary of Thermo Fisher Scientific, specializes in advanced...
- The Defense Health Agency awarded a $79,572.42 firm fixed-price Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on January 21, 2026, for reagent testing supplies to support allergic reaction detection and management at a military medical treatment facility in Portage, Michigan. The contract is scheduled for completion by September 30, 2026, and was awarded through open market procurement without set-aside designation. Phadia US Inc., a foreign-owned...
- The Defense Health Agency awarded a $371,588.52 firm fixed price BPA call to One Lambda, Inc. for test kits supporting organ transplantation compatibility assessment prior to surgery. The contract, issued on September 25, 2024, with an ultimate completion date of September 24, 2025, will be performed in Bethesda, Maryland. This procurement was conducted as an open competition with no set-aside designation and represents a task order under One Lambda's existing $7.5 million Blanket Purchase...
The Defense Health Agency awarded a $428,650 firm fixed-price purchase order to National Jewish Health for beryllium lymphocyte proliferation test services, with an ultimate completion date of January 31, 2031. The contract was awarded on February 1, 2026, with no set-aside designation applied. Performance will be conducted at Joint Base Pearl Harbor-Hickam in Hawaii. National Jewish Health, a non-profit hospital and research center headquartered in Denver, Colorado, specializes in respiratory, immune, and related disorders and maintains an established track record of providing specialized laboratory testing services to federal health agencies. Beryllium lymphocyte proliferation testing is a diagnostic service used to identify beryllium sensitization and chronic beryllium disease, conditions of occupational health significance to the Department of Defense workforce. The Defense Health Agency leverages such specialized testing capabilities through partnerships with leading medical institutions to support occupational health screening and clinical care for military personnel and beneficiaries. National Jewish Health's expertise in immunological testing and its existing federal contract portfolio demonstrate its qualifications to deliver these diagnostic services throughout the contract performance period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 1/27/26 |